OTS514 hydrochloride(1338540-63-8(free base))

Research use only, not for human use.

OTS514 is a highly effective TOPK(T-LAK cell-originated protein kinase) inhibitor (IC50: 2.6 nM).

OTS514 is a highly effective TOPK(T-LAK cell-originated protein kinase) inhibitor (IC50: 2.6 nM).

OTS514 (1.5625-100 nM) induces cell cycle arrest and apoptosis at nanomolar concentrations in a series of human myeloma cell lines (HMCL) and prevents outgrowth of a putative CD138+ stem cell population from multiple myeloma (MM) patient-derived peripheral blood mononuclear cells. Cell Viability Assay Cell Line:Human myeloma cell lines (MM1.S, MM1.R, RPMI 8226, 8226Dox40, KMS34, KMS34CFZ, KMS11, JJN3, LP-1, NCI H929, U266B1) Concentration:1.5625, 3.125, 6.25, 12.5, 25, 50, and 100 nM Incubation Time:72 hours Result:IC50 values ranged from 11.6 to 29.4 nM in parental cell lines, indicating a potent inhibitory effect. Only the RPMI 8226-Dox40 cell line, which overexpresses the multi-drug resistance transporter gene ABCB1, was resistant.

OTS514 (1-5 mg/kg; once a day for 2 weeks; intravenous administration) induces tumor regression in a xenograft model of A549 cells (TOPK-positive lung cancer cells). Animal Model:Female BALB/cSLC-nu/nu mice bearing a xenograft model of A549 cellsDosage:1, 2.5, and 5 mg/kgAdministration:Intravenously treated; once every day for 2 weeks Result:Resulted in tumor growth inhibition (TGI) of 5.7, 43.3, and 65.3% on day 15, respectively, without any body weight loss.

OTS-514 hydrochloride

Others

Other Targets

TOPK

——

——

2319647-76-0

400.92

C21H20N2O2S.HCl

>98% (HPLC)

DMSO:10 mM

Cl.C[C@@H](CN)c1ccc(cc1)-c1c(O)cc(C)c2[nH]c(=O)c3sccc3c12

——

(-20℃)

With Ice Pack

≥ 2 years